Repligen
RGENPhase 3Repligen is a bioprocessing-focused life sciences company that has been inspiring advances in bioprocessing since 1981. The company develops and commercializes high-value products and flexible solutions that address critical steps in biologic drug production, positioning itself as a technology leader in perfusion, pre-packed columns, and integrated tangential flow filtration systems. With global operations and a focus on process intensification and single-use technologies, Repligen is the fastest-growing bioprocessing tools provider, driven by innovative product development and strategic acquisitions including recent acquisitions of Metenova and FlexBiosys.
RGEN · Stock Price
Historical price data
AI Company Overview
Repligen is a bioprocessing-focused life sciences company that has been inspiring advances in bioprocessing since 1981. The company develops and commercializes high-value products and flexible solutions that address critical steps in biologic drug production, positioning itself as a technology leader in perfusion, pre-packed columns, and integrated tangential flow filtration systems. With global operations and a focus on process intensification and single-use technologies, Repligen is the fastest-growing bioprocessing tools provider, driven by innovative product development and strategic acquisitions including recent acquisitions of Metenova and FlexBiosys.
Technology Platform
Comprehensive bioprocessing platform including chromatography systems, tangential flow filtration, fluid management solutions, and process analytics for biologic drug manufacturing.
Pipeline Snapshot
1010 drugs in pipeline, 3 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| RG1068 (Synthetic Human Secretin) | Autism | Phase 3 |
| RG1068 (synthetic human secretin) | Pancreatitis | Phase 3 |
| RG1068 (Synthetic Human Secretin) | Autism | Phase 3 |
| RG2417 + Placebo | Bipolar I Depression | Phase 2 |
| Subcutaneous Secretin | Schizophrenia | Phase 2 |
Opportunities
Risk Factors
Competitive Landscape
Repligen competes as the fastest-growing bioprocessing tools provider, differentiating through first-to-market innovations and comprehensive integrated solutions. The company maintains competitive advantages through technological leadership, global commercial reach, and deep customer relationships built over four decades in the bioprocessing industry.
Company Info
Trading
Contact
Therapeutic Areas
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile